ライフサイエンスコーパス: influenza-like illness

1 ted to 8 healthcare facilities in Kenya with influenza-like illness.

2 during the study period who did not have an influenza-like illness.

3 to sentinel sites within 7 days of onset of influenza-like illness.

4 in respiratory secretions from a child with influenza-like illness.

5 ied to historical data sets of patients with influenza-like illness.

6 and 95.6% specific (90.0-98.5) compared with influenza-like illness.

7 ontrols with community-acquired pneumonia or influenza-like illness.

8 lized adults older than 65 years of age with influenza-like illness.

9 903) against acute respiratory infections or influenza-like illness.

10 tained from participants with symptoms of an influenza-like illness.

11 test-negative design among outpatients with influenza-like illness.

12 n multiple occasions and 1 employee reported influenza-like illness.

13 as a proxy for complications of influenza or influenza-like illness.

14 primary or ambulatory care with influenza or influenza-like illness.

15 tory illnesses (ARIs), which may manifest as influenza-like illness.

16 Disease Control and Prevention criteria for influenza-like illness.

17 Among 48 nonhospitalized children with influenza-like illness, 1 or more respiratory pathogens

18 Human monocytic ehrlichiosis, an influenza-like illness accompanied by signs of hepatitis

19 -analyses showed significantly lower odds of influenza-like illness after vaccination in patients wit

20 d one anaphylaxis) and one possibly related (influenza-like illness); all three recovered without seq

21 on than standard-dose IIV4 against confirmed influenza-like illness among older adults.

22 In 1998, there was an outbreak of influenza-like illness among swine that was caused by A(

23 gs were related to the clinical incidence of influenza-like illness and acute bronchitis at that time

24 ive in preventing total respiratory illness (influenza-like illness and clinically diagnosed pneumoni

25 2,595-428,286) attended 35,663 patients with influenza-like illness and collected 13,925 respiratory

26 inactivated influenza vaccine in preventing influenza-like illness and influenza-associated pneumoni

27 ocompromised patients in terms of preventing influenza-like illness and laboratory confirmed influenz

28 ated significant protective associations for influenza-like illness and laboratory-confirmed influenz

29 ngeal swabs were collected from persons with influenza-like illness and tested for influenza virus by

30 were hospitalized for at least 24 hours for influenza-like illness and who tested positive for the 2

31 Patients with influenza-like illness and/or positive rapid test result

32 teen percent of household contacts developed influenza-like illness, and 10% of household contacts ha

33 rted in 3289 (28.7%) of 11,459 patients with influenza-like illness, and antivirals were prescribed t

34 ospitalized with pneumonia, outpatients with influenza-like illness, and asymptomatic control patient

35 Severe outcome included conjunctivitis, influenza-like illness, and one lethal infection.

36 percentage of outpatient doctors visits for influenza-like illness, and the season onset, duration,

37 to participating general practitioners with influenza-like illness are swabbed for laboratory testin

38 easons for the rapid and extensive spread of influenza-like illnesses are unknown.

39 influenza illness, defined as development of influenza-like illness associated with influenza virus o

40 events were headache, fatigue, pyrexia, and influenza-like illness at 12 weeks (95 [37%) vs 45 [34%]

41 y specimens from outpatients presenting with influenza-like illness at 13 facilities in order to inve

42 oint was RT-PCR-confirmed, protocol defined, influenza-like illness between 14 days or more after vac

43 y collected NPS specimens from patients with influenza-like illness between February 2008 and 28 May

44 hospital admissions related to pulmonary and influenza-like illness between Nov 1, 2013, and May 31,

45 action (RT-PCR)-confirmed, protocol-defined, influenza-like illness caused by any influenza strain st

46 We found no difference in the odds of influenza-like illness compared to vaccinated immunocomp

47 Vaccine effect was demonstrated for the influenza-like illness consultation outcome using the Co

48 a A/H3N2, A/H1N1, and B that combine data on influenza-like illness consultations and respiratory spe

49 Active surveillance for influenza-like illnesses continued from days 14 to 385.

50 n either the community-acquired pneumonia or influenza-like illness controls.

51 Influenza-like illness data are collected via an Influen

52 These were combined with influenza-like illness data to derive measures of influe

53 respect to efficacy was laboratory-confirmed influenza-like illness (defined as a temperature of at l

54 If an influenza-like illness developed in one member, the fami

55 and measured when they were symptomatic with influenza-like illness during the 2009 A/H1N1pdm influen

56 tics, influenza vaccination, and outcomes of influenza-like illness during the previous 7 days.

57 of employee respondents) reported having an influenza-like illness during this period.

58 resented to general practices in the UK with influenza-like illnesses during three successive winters

59 from the first ten patients presenting with influenza-like illness each week.

60 muting flows and predict the diffusion of an influenza-like-illness epidemic.

61 with an 80% effective vaccine to prevent one influenza-like illness episode.

62 of influenza activity and the risk of acute influenza-like illness episodes among 8,323 healthy preg

63 We recorded 5279 influenza-like illness episodes in 2789 (68%) infants, o

64 f association between influenza exposure and influenza-like illness episodes increased as the pregnan

65 Influenza-like illness episodes were identified from med

66 The authors compared the occurrence of influenza-like illness episodes within each pregnancy st

67 e association between influenza activity and influenza-like illness episodes.

68 The most common adverse events were influenza-like illness, fatigue, anemia, and neutropenia

69 group had constitutional signs and symptoms (influenza-like illness, fatigue, fever, and chills) than

70 jurisdictions in the USA reported counts of influenza-like illness (fever including cough or sore th

71 We examined outpatients with influenza-like illness for HBoV infection and tested for

72 We report prospective influenza-like-illness forecasts made for the 2013-2014

73 Emergency department visits for influenza-like illness, grouped by age (>/=0 years and >

74 s with confirmed 2009 H1N1 influenza or with influenza-like illness had severe symptoms.

75 ystem for influenza that includes virologic, influenza-like illness, hospitalization, and mortality d

76 analyze the spatio-temporal distribution of Influenza Like Illness (ILI) in the city of Jerusalem ov

77 95% confidence interval [CI]:0.46-0.77) and influenza-like illness (ILI) (RR = 0.34; 95% CI:0.14-0.8

78 of 9 donors developed symptoms consistent an influenza-like illness (ILI) and 7 of 9 were proven to b

79 Confirmed cases had influenza-like illness (ILI) and a positive laboratory t

80 Outpatients with influenza-like illness (ILI) and inpatients with severe

81 hospitals across the country, patients with influenza-like illness (ILI) and severe acute respirator

82 We conducted ISS by monitoring patients with influenza-like illness (ILI) and severe acute respirator

83 08, we established sentinel surveillance for influenza-like illness (ILI) and severe acute respirator

84 Callers were evaluated for symptoms of influenza-like illness (ILI) and were prescribed an anti

85 za surveillance for patients presenting with influenza-like illness (ILI) at 136 private and public c

86 ng laboratory-confirmed cases than syndromic influenza-like illness (ILI) cases.

87 National Laboratory Surveillance System, and influenza-like illness (ILI) data were collected from Da

88 nd oropharyngeal swabs were collected during influenza-like illness (ILI) episodes and from controls.

89 rveillance in children <11 years old who had influenza-like illness (ILI) from January 2008 to Decemb

90 ory system for the syndromic surveillance of influenza-like illness (ILI) in Europe.

91 t-Kenya (USAMRU-K) conducts surveillance for influenza-like illness (ILI) in Kenya.

92 estimating, in near-real time, the level of influenza-like illness (ILI) in the United States (US) b

93 lthcare-seeking behaviors among persons with influenza-like illness (ILI) or adherence to influenza a

94 patients seen in the outpatient clinic with influenza-like illness (ILI) or hospitalized with severe

95 al (NP/OP) swab specimens from patients with influenza-like illness (ILI) or severe acute respiratory

96 We prospectively enrolled outpatients with influenza-like illness (ILI) presenting at 14 sentinel c

97 ce for acute respiratory infection (ARI) and influenza-like illness (ILI) relies primarily on reports

98 n methods with Wikipedia access logs and CDC influenza-like illness (ILI) reports to create a weekly

99 of schools closed within a district to state influenza-like illness (ILI) surveillance data, we measu

100 The goal of influenza-like illness (ILI) surveillance is to determin

101 atory symptoms not meeting ILI criteria) and influenza-like illness (ILI) to determine the incidence

102 tioners sent throat swabs from patients with influenza-like illness (ILI) to the National Institute f

103 nfluenza vaccines LAIV and TIV in preventing influenza-like illness (ILI) was compared among US milit

104 Active surveillance for influenza-like illness (ILI) was conducted on 4455 child

105 onths to <10 years at first vaccination with influenza-like illness (ILI) was evaluated in Australia,

106 Influenza-like illness (ILI) was reported by 79 of 702 h

107 .3% against a febrile episode, 53.5% against influenza-like illness (ILI), 41.8% against related heal

108 icipatory surveillance data on self-reported influenza-like illness (ILI), defined here as self-repor

109 percent of influenza-positive patients with influenza-like illness (ILI), or severe acute respirator

110 ks and hand hygiene reduced the incidence of influenza-like illness (ILI).

111 ry pathogens in individuals >/=65 years with influenza-like illness (ILI).

112 ter within 3 days of donation complaining of influenza-like illness (ILI).

113 the difference in the rates of self-reported influenza-like illness (ILI, defined as presence of feve

114 uration of URTI and its composite syndromes, influenza-like illness (ILI; fever and >/=2 of sore thro

115 contribution consists of combining multiple influenza-like illnesses (ILI) activity estimates, gener

116 Here, we define and analyze influenza-like-illness (ILI) case data from 2009-2010 fo

117 surrogates for clinically-based reporting of influenza-like-illness (ILI).

118 maceutical sales and volume of patients with influenza-like-illnesses (ILI) at an urgent care center

119 gated the spatiotemporal association between influenza-like illnesses (ILIs) and licensed swine opera

120 se of acute histoplasmosis was defined as an influenza-like illness in a plant employee with the onse

121 ge numbers of Google search queries to track influenza-like illness in a population.

122 tamivir for treatment of naturally occurring influenza-like illness in adults reporting at least one

123 ta were collected from walk-in patients with influenza-like illness in Egypt during routine influenza

124 Recent reports of mild to severe influenza-like illness in humans caused by a novel swine

125 ), a virus sensed by STING that can cause an influenza-like illness in humans.

126 from children in a pediatric cohort study of influenza-like illness in Managua, Nicaragua, between Ju

127 lymerase chain reaction (PCR) to undiagnosed influenza-like illness in New York State led to the disc

128 primary outcomes: the incidence of maternal influenza-like illness in pregnancy and 0-180 days postp

129 roportion of specimens from outpatients with influenza-like illness in the community that tested posi

130 s well tolerated, but more patients reported influenza-like illness in the hydroxychloroquine group c

131 012 during population-based surveillance for influenza-like illness in two rural provinces.

132 immunisation significantly reduced maternal influenza-like illness, influenza in infants, and low bi

133 d adult caregivers self-triage children with influenza-like illness is feasible.

134 visited weekly until age 6 months to detect influenza-like illness; laboratory-confirmed influenza d

135 elevated percentage of outpatient visits for influenza-like illness occurred an average of 14 days af

136 Seven cases of culture-confirmed CDC-defined influenza-like illness occurred in 153 placebo recipient

137 ract infection, urinary tract infection, and influenza-like illness occurred in only 26, 9, and 7 ret

138 es showed a significant effect of preventing influenza-like illness (odds ratio [OR]=0.23; 95% confid

139 A total of 417 adults with influenza-like illness of < or =48 hours' duration were

140 ly healthy non-immunised adults with febrile influenza-like illness of up to 36 h duration.

141 Here we quantified the impact of influenza-like illness on social mixing patterns.

142 ed, but the specific effect of influenza and influenza-like illnesses on triggering acute myocardial

143 nal pain (one [7%]), fatigue (one [7%]), and influenza-like illness (one [7%]) in three patients trea

144 ing to a sentinel physician within 7 days of influenza-like illness onset.

145 ng 2010 from inpatients and outpatients with influenza-like illness or severe acute respiratory illne

146 ties in Addis Ababa met case definitions for influenza-like illness or severe acute respiratory illne

147 es without swine exposure were identified in influenza-like illness outbreaks, indicating that limite

148 We simulate an influenza-like illness over the contact network to evalu

149 he original model significantly mispredicted influenza-like illness rates in the US during the 2012-1

150 r subtype associated with a protocol-defined influenza-like illness (relative efficacy, 24.2%; 95% co

151 We conducted sentinel surveillance for influenza-like illness, severe acute respiratory illness

152 prompt evaluation and antiviral treatment of influenza-like illness should be considered in such wome

153 n applied to redesigning the provider-based, influenza-like-illness surveillance network (ILINet) for

154 s had twice the risk of developing secondary influenza-like illness than contacts of HIV-negative ind

155 g winter 2004, there was a high incidence of influenza-like illness that tested negative both for inf

156 In individuals diagnosed with influenza-like illness, there is a substantial potential

157 infection ranges in disease severity from an influenza-like illness to life-threatening shock.

158 We calculated the incidence of visits for influenza-like illness using the size of the patient pop

159 The probability of influenza-like illness was 30% lower with RIV4 than with

160 Weekly telephone surveillance for influenza-like illness was conducted during the influenz

161 e and the use of aspirin during varicella or influenza-like illness was first reported, there has bee

162 Influenza-like illness was monitored with cultures throu

163 os across trials for all-cause mortality and influenza-like illness were 0.71 (95% confidence interva

164 Emergency department visits for influenza-like illness were associated with and predicti

165 influenza was circulating and those coded as influenza-like illness were associated with consistently

166 Specimens from patients presenting with influenza-like illness were collected and shipped to the

167 he 2010-2011 influenza season, subjects with influenza-like illness were enrolled in an emergency dep

168 Nonhospitalized UC with influenza-like illness were interviewed, and nasopharyng

169 Most outcomes related to influenza-like illness were significantly lower in inter

170 ute respiratory illness and outpatients with influenza-like illness were tested by real-time reverse

171 Patients attended with influenza-like illness were tested for influenza.

172 Nose and throat samples obtained during influenza-like illnesses were tested for A/California/7/

173 cted specimens from patients presenting with influenza-like illness who visited sentinel surveillance

174 Immunisation reduced maternal febrile influenza-like illness with an overall efficacy of 19% (